Inhaled pulmonary vasodilators in the neonatal and pediatric ICU

Keyphrases

• Neonatal ICU 100%
• Pediatric ICU 100%
• Inhaled Vasodilators 100%
• Exhaled Nitric Oxide 60%
• Neonate 20%
• Pediatric 20%
• Nitric Oxide Production 20%
• Gestational Age 20%
• Pulmonary Hypertension 20%
• Evidence-based Treatment 20%
• Neonatal Intensive Care 20%
• Pediatric Population 20%
• Absence of Evidence 20%
• Off-label Use 20%
• Pediatric Intensive Care 20%
• Persistent Pulmonary Hypertension of the Newborn 20%
• Delivery Device 20%
• Generation Device 20%
• Nitric Oxide Delivery 20%
• Advancement in Technology 20%

Medicine and Dentistry

• Pediatrics 100%
• Nitric Oxide 100%
• Peripheral Vasodilating Agent 100%
• Vasodilator Agent 75%
• Neonate 25%
• Health Care Cost 25%
• Neonatal Infant 25%
• Vasoactive Agent 25%
• Combined Therapy 25%
• Gestational Age 25%
• Pulmonary Hypertension 25%
• Newborn Intensive Care 25%
• Intensive Care 25%
• Persistent Fetal Circulation 25%
• Off-Label Use 25%